Mymetics (QB) Stock Price - MYMX

-0.007 (-17.95%)
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Ultimate Trader
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Mymetics Corporation (QB) MYMX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.007 -17.95% 0.032 0.032 0.0389 0.038495 0.039 10:04:29
Bid Price Ask Price Spread Spread % News
0.032 0.0389 0.0069 17.74% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5 50,000 $ 0.035699 $ 1,785 56,555 0.0201 - 0.059
Last Trade Time Type Quantity Stock Price Currency
10:44:20 10,000 $ 0.032 USD

Mymetics (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 9.72M 303.76M $ -4.17M - - 79.76M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
4.43k $ - 0.00% - -

more financials information »

Mymetics (QB) News

Loading Messages....

Latest MYMX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MYMX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.03790.03990.02690.0333084134,664-0.0059-15.57%
1 Month0.0340.03990.02690.033378157,989-0.002-5.88%
3 Months0.0350.040.0240.035677956,835-0.003-8.57%
6 Months0.040280.0430.0240.037147555,461-0.00828-20.56%
1 Year0.040.0590.02010.037014871,120-0.008-20.0%
3 Years0.01890.0950.0150.0426847239,0790.013169.31%
5 Years0.02370.0950.0080.0379131199,2850.008335.02%

Mymetics (QB) Description

Mymetics Corporation is US registered biotechnology company with its main offices in Switzerland and the Netherlands. Focused on developing next generation vaccines for infectious and life threatening diseases. Mymetics core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins in combination with rationally designed antigens and membrane proteins. Mymetics currently has the following vaccines in its pipeline: HIV/AIDS. intranasal Influenza, RSV, Malaria and Chikungunya and collaboration projects in the allergy and cancer immunotherapy field.

Your Recent History
Mymetics (..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.